Abbott launches COVID-19 antibody test, plans 20 million tests per month by June [Reuters]

Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
Abbott launches COVID-19 antibody test, plans 20 million tests per month by June (Reuters) - Abbott Laboratories Inc said on Wednesday it launched a coronavirus blood test that could show whether a person has been infected and plans to ramp up manufacturing to produce 20 million tests per month by June. The test helps identify disease-fighting antibodies in people who have been infected but may have had mild symptoms or none at all, making it different from the current diagnostic tests that require nasal swabs to confirm active infection. Antibody tests are considered a potential game changer in the battle to contain infections and offers the chance to get the economy back on track by identifying people who may have immunity to the virus and could return to their jobs. The company said it plans to file for FDA approval for its test through the emergency use pathway. Last month, the U.S. Food and Drug Administration relaxed the rules on use of diagnostic tests by allowing body-fluid te
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Bank of America Co. from $125.00 to $115.00.MarketBeat
- Abbott Hosts Conference Call for First-Quarter EarningsPR Newswire
- FDA sketches out plan to bolster fragile US infant formula supply management [CBS News]CBS News
- FDA sketches out plan to bolster fragile US infant formula supply management [CNN]CNN
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.MarketBeat
ABT
Earnings
- 1/25/23 - Beat
ABT
Sec Filings
- 3/17/23 - Form ARS
- 3/17/23 - Form DEFA14A
- 3/17/23 - Form DEF
- ABT's page on the SEC website